Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study-Reference-Cited by-同舟云学术

Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study

Published:2021-05-06 Issue: Volume: Page:1-10
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Basu Indraneel¹,Agarwal Manish²,Shah Viral³,Shukla Vijay⁴,Naik Sunil⁵,Supe Pravin Dinkar⁶,Srivastava Manoj Kumar⁷,Giriraja Kanakapura Vrushabaiah⁸,Pinjar Peersab⁹,Mishra Pradeep Kumar¹⁰,Joshi Shishir¹¹,Vijayakumar Ranjit¹²,van de Witte Serge¹³

Affiliation:

1. Department of Medicine, Popular Hospital, Varanasi, Uttar Pradesh, India

2. Department of Medicine, Medilink Hospital Research Centre, Ahmedabad, Gujrat, India

3. Department of Medicine, Panchshil Hospital, Ahmedabad, Gujarat, India

4. Department of Ear, Nose and Throat, Ajanta Research Centre, Lucknow, Uttar Pradesh, India

5. Department of Medicine, Rajiv Gandhi Institute of Medical Sciences, Adilabad, Andhra Pradesh, India

6. Department of Medicine, Supe Heart and Diabetes Hospital and Research Center, Nasik, Maharashtra, India

7. Department of Medicine, OM Research Centre, Varanasi, Uttar Pradesh, India

8. Department of General Medicine, Sapthagiri Institute of Medical Science & Research Centre, Bangalore, Karnataka, India

9. Department of General Medicine, S.S Institute of Medical Sciences and Research Center, Davangere, Karnataka, India

10. Department of General Medicine, Yashoda Hospital, Secunderabad, Andhra Pradesh, India

11. Department of Medicine, Sahyadri Hospital, Pune, Maharashtra, India

12. Department of General Medicine, Krishna Rajendra Hospital, Mysuru, Karnataka, India

13. Established Pharmaceuticals Division, Abbott Healthcare Products B.V, Weesp, The Netherlands

Funder

Abbott India

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1885278

Reference33 articles.

1. Immunization Action Coalition. 2020 [Accessed 2020 Feb 6th]; https://www.immunize.org/catg.d/p4208.pdf

2. WHO Influenza (Seasonal). 2020 [Accessed 2021 Feb 15]; https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)

3. Centers for Disease Control and Prevention 2020 [Accessed 2021 Feb 15]; https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm

4. National Institute of allergy and Infectious Diseases. 2020 [Accessed 2020 Mar 4]; https://www.niaid.nih.gov/diseases-conditions/influenza-diagnosis

5. CDC Antiviral Drugs. 2020 [Accessed 2021 Feb 15]; https://www.cdc.gov/flu/treatment/whatyoushould.htm

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Level of influenza virus strain antibodies in healthy vaccinated people at the end of the COVID-19 pandemic;Russian Journal of Infection and Immunity;2024-04-28

2. Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity;Expert Review of Vaccines;2023-12-15

3. A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine Among Persons With HIV With Different Levels of CD4 Cell Count;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-07-01

4. A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent);Vaccine;2023-03

5. Side effects of vaccines;Side Effects of Drugs Annual;2023